{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:29:43Z","timestamp":1785457783405,"version":"3.56.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003359","name":"Scoliosis Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ucl.2025.07.010","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T19:40:44Z","timestamp":1756237244000},"page":"547-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["UroLift, Rez\u016bm, and iTind for Benign Prostatic Hyperplasia"],"prefix":"10.1016","volume":"52","author":[{"given":"Amandip S.","family":"Cheema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn G.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"McVary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2025.07.010_bib1","first-page":"530","article-title":"AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations","volume":"170","author":"Roehrborn","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","article-title":"Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients","volume":"180","author":"Reich","year":"2008","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ucl.2016.04.008","article-title":"Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"43","author":"Roehrborn","year":"2016","journal-title":"Urol Clin"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.010_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0302-2838(03)00376-2","article-title":"Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project","volume":"44","author":"Verhamme","year":"2003","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.ucl.2025.07.010_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11934-021-01081-7","article-title":"Office-based procedures for BPH","volume":"22","author":"Gao","year":"2021","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.010_bib6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1743-6109.2011.02568.x","article-title":"Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"9","author":"Woo","year":"2012","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","article-title":"The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT Study","volume":"190","author":"Roehrborn","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","article-title":"Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study","volume":"68","author":"S\u00f8nksen","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib9","first-page":"548","article-title":"Clinical significance of intravesical prostatic protrusion in the management of benign prostatic enlargement: a systematic review and critical analysis of current evidence","volume":"69","author":"Rieken","year":"2017","journal-title":"Minerva Urologica e Nefrologica= The Italian Journal of Urology and Nephrology"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/JU.0000000000002184","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part II\u2014surgical evaluation and treatment","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I\u2014initial work-up and medical management","volume":"206","author":"Lerner","year":"2021","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","article-title":"Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the MedLift study","volume":"22","author":"Rukstalis","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.purol.2021.09.003","article-title":"La pose d\u2019implant UroLift\u00ae sous anesth\u00e9sie locale: \u00e9tude observationnelle r\u00e9trospective monocentrique","volume":"32","author":"Dupitout","year":"2022","journal-title":"Prog Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib14","first-page":"10213","article-title":"Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection","volume":"27","author":"Tutrone","year":"2020","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib15","first-page":"7094","article-title":"Prospective multi-center study elucidating patient experience after prostatic urethral lift","volume":"21","author":"Shore","year":"2014","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1464-410X.2011.10342.x","article-title":"Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)","volume":"108","author":"Woo","year":"2011","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib17","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urpr.2014.08.001","article-title":"Durability of the prostatic urethral lift: 2-year results of the L.I.F.T. Study","volume":"2","author":"Roehrborn","year":"2015","journal-title":"Urology Practice"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib19","first-page":"7772","article-title":"Three year results of the prostatic urethral LIFT study","volume":"22","author":"Roehrborn","year":"2015","journal-title":"Can J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ucl.2016.04.008","article-title":"Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"43","author":"Roehrborn","year":"2016","journal-title":"Urol Clin North Am"},{"issue":"7","key":"10.1016\/j.ucl.2025.07.010_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1089\/end.2019.0167","article-title":"Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study","volume":"33","author":"Eure","year":"2019","journal-title":"J Endourol"},{"issue":"5S2","key":"10.1016\/j.ucl.2025.07.010_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0001015816.87470.c9.13","article-title":"P2-13 preliminary RCT analysis of minimally invasive surgery vs. medication in the initial treatment OF BPH-associated LUTS","volume":"211","author":"Brodak","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.07.010_bib23","unstructured":"Food US, Drug A. 510(k) Premarket Notification K150786. 02\/20\/2025."},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/02656730310001637343","article-title":"In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia","volume":"20","author":"Bhowmick","year":"2004","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ucl.2025.07.010_bib25","first-page":"13","article-title":"Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rez\u016bm\u00ae system: evaluation of acute ablative capabilities in the human prostate","author":"Dixon","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.ucl.2025.07.010_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0302-2838(23)00284-1","article-title":"Rez\u016bm water vapour therapy (Rez\u016bm): is it safe to continue antiplatelet or anticoagulation medication?","volume":"83","author":"Lee","year":"2023","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"10.1016\/j.ucl.2025.07.010_bib27","first-page":"82","article-title":"Evolving and investigational therapies for benign prostatic hyperplasia","volume":"22","author":"Nair","year":"2015","journal-title":"Can J Urol"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.010_bib28","doi-asserted-by":"crossref","DOI":"10.5489\/cuaj.8535","article-title":"Anesthetic options for Rez\u016bm water vapor therapy: is minimal sedation tolerable for a minimally invasive procedure?","volume":"18","author":"Bal","year":"2024","journal-title":"Canadian Urological Association Journal"},{"issue":"9","key":"10.1016\/j.ucl.2025.07.010_bib29","article-title":"Evaluating the efficacy of employing local anesthetic prostatic blocks during Rezum procedure","volume":"14","author":"Gilpin","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ucl.2016.04.005","article-title":"Convective water vapor energy for lower urinary tract symptoms\/benign prostatic hyperplasia","volume":"43","author":"DeLay","year":"2016","journal-title":"Urol Clin"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.010_bib31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","article-title":"Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"195","author":"McVary","year":"2016","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib32","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","article-title":"Convective thermal therapy: durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"197","author":"Roehrborn","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.07.010_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.urology.2017.10.023","article-title":"Three-year outcomes of the prospective, randomized controlled Rez\u016bm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"111","author":"McVary","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2025.07.010_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","article-title":"Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study","volume":"126","author":"McVary","year":"2019","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.010_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.010_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.juro.2018.02.3088","article-title":"Three-year treatment outcomes of water vapor thermal therapy compared to doxazosin, finasteride and combination drug therapy in men with benign prostatic hyperplasia: cohort data from the MTOPS trial","volume":"200","author":"Gupta","year":"2018","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00345-023-04739-8","article-title":"Rez\u016dm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience","volume":"42","author":"Tayeb","year":"2024","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib38","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/bju.15753","article-title":"Rez\u016bm therapy for\u2265 80-mL benign prostatic enlargement: a large, multicentre cohort study","volume":"130","author":"Elterman","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2025.07.010_bib39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.urology.2022.02.001","article-title":"Large, multi-center, prospective registry of Rez\u016bm water vapor therapy for benign prostatic hyperplasia","volume":"165","author":"Elterman","year":"2022","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.ucl.2025.07.010_bib40","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1089\/end.2020.0177","article-title":"Comparative postoperative outcomes of Rez\u016bm prostate ablation in patients with large versus small glands","volume":"34","author":"Bole","year":"2020","journal-title":"J Endourol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib41","doi-asserted-by":"crossref","first-page":"100454","DOI":"10.1016\/j.esxm.2021.100454","article-title":"Preservation of sexual function 5 years after water vapor thermal therapy for benign prostatic hyperplasia","volume":"9","author":"McVary","year":"2021","journal-title":"Sex Med"},{"issue":"12","key":"10.1016\/j.ucl.2025.07.010_bib42","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.jsxm.2018.10.006","article-title":"Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia?","volume":"15","author":"McVary","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.ucl.2025.07.010_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","article-title":"The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial","volume":"153","author":"Chughtai","year":"2021","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.010_bib44","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bju.14141","article-title":"3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction","volume":"122","author":"Porpiglia","year":"2018","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.010_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/bju.12982","article-title":"Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results","volume":"116","author":"Porpiglia","year":"2015","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.ucl.2025.07.010_bib46","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1007\/s00345-020-03140-z","article-title":"Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study","volume":"38","author":"Kadner","year":"2020","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/bju.14608","article-title":"Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up","volume":"123","author":"Porpiglia","year":"2019","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.010_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41391-020-00281-5","article-title":"3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction","volume":"24","author":"Amparore","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Supplement 3","key":"10.1016\/j.ucl.2025.07.010_bib49","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1097\/JU.0000000000001982.04","article-title":"MP09-04 iTind for the treatment of LUTS secondary to BPH IN polymorphic patients: those in acute urinary retention and on anti-coagulants","volume":"206","author":"Kadner","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.07.010_bib50","article-title":"A randomized clinical trial on the use of iTind in acute urinary retention","year":"2025","journal-title":"Health Research Authority"},{"issue":"Supplement_1","key":"10.1016\/j.ucl.2025.07.010_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/jsxmed\/qdae001.347","article-title":"(362) stress urinary incontinence rates in men undergoing optilume balloon dilation for radiation-induced posterior urethral stenosis: a single center experience","volume":"21","author":"Ceballos","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/j.ucl.2025.07.010_bib52","first-page":"1","article-title":"Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure","volume":"10","author":"Secco","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.010_bib53","first-page":"10788","article-title":"How i do it: temporarily implanted nitinol device (iTind)","volume":"28","author":"Elterman","year":"2021","journal-title":"Can J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib54","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00345-020-03418-2","article-title":"Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study","volume":"39","author":"De Nunzio","year":"2021","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.010_bib55","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","article-title":"Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis","volume":"83","author":"Cornu","year":"2023","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.010_bib56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/bju.16304","article-title":"Systematic review and network meta-analysis of re-intervention rates of new surgical interventions for benign prostatic hyperplasia","volume":"134","author":"Shin","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2025.07.010_bib57","first-page":"1","article-title":"Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature","volume":"22","author":"Lambertini","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:25:16Z","timestamp":1760567116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0094014325000655"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.010","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UroLift, Rez\u016bm, and iTind for Benign Prostatic Hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}